254 related articles for article (PubMed ID: 35904534)
1. Prognostic value of exosomal noncoding RNA in hepatocellular carcinoma: a meta-analysis.
Nie G; Lian N; Peng D; Lu J; Li B
Carcinogenesis; 2022 Sep; 43(8):754-765. PubMed ID: 35904534
[TBL] [Abstract][Full Text] [Related]
2. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
4. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
[TBL] [Abstract][Full Text] [Related]
5. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of long non-coding RNAs in hepatocellular carcinoma: An updated meta-analysis.
Liu J; Wei Y; Wang T; Zhang Z; Huang H; Wang C; Li H; Jia Q; Wu H; Zou T
Int J Biol Markers; 2020 Dec; 35(4):3-11. PubMed ID: 33208027
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive Analysis of Competing Endogenous RNA Network Focusing on Long Noncoding RNA Involved in Cirrhotic Hepatocellular Carcinoma.
Zhang Y; Chen D; Yang M; Qian X; Long C; Zheng Z
Anal Cell Pathol (Amst); 2021; 2021():5510111. PubMed ID: 34258170
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive analysis of the competing endogenous circRNA-lncRNA-miRNA-mRNA network and identification of a novel potential biomarker for hepatocellular carcinoma.
Zhang L; Tao H; Li J; Zhang E; Liang H; Zhang B
Aging (Albany NY); 2021 May; 13(12):15990-16008. PubMed ID: 34049287
[TBL] [Abstract][Full Text] [Related]
9. The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma.
Zhang Z; Li J; He T; Ouyang Y; Huang Y; Liu Q; Wang P; Ding J
Cancer Sci; 2019 Sep; 110(9):2905-2923. PubMed ID: 31335995
[TBL] [Abstract][Full Text] [Related]
10. Decoding hepatocarcinogenesis from a noncoding RNAs perspective.
El-Aziz MKA; Dawoud A; Kiriacos CJ; Fahmy SA; Hamdy NM; Youness RA
J Cell Physiol; 2023 Sep; 238(9):1982-2009. PubMed ID: 37450612
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis of the Utility of Circular RNAs as Biomarkers of Hepatocellular Carcinoma.
Hao Q; Han Y; Xia W; Wang Q; Qian H
Can J Gastroenterol Hepatol; 2019; 2019():1684039. PubMed ID: 31187026
[TBL] [Abstract][Full Text] [Related]
12. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
13. Non-coding RNA in drug resistance of hepatocellular carcinoma.
Ding B; Lou W; Xu L; Fan W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30224380
[TBL] [Abstract][Full Text] [Related]
14. Exosomal noncoding RNAs as noninvasive biomarkers in bladder cancer: a diagnostic meta-analysis.
Zhao L; Li J; Xue Z; Wang J
Clin Transl Oncol; 2024 Jun; 26(6):1497-1507. PubMed ID: 38227115
[TBL] [Abstract][Full Text] [Related]
15. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
16. Circular Noncoding RNA hsa_circ_0003570 as a Prognostic Biomarker for Hepatocellular Carcinoma.
Jang SY; Kim G; Tak WY; Kweon YO; Lee YR; Han YS; Han JR; Park JG; Kang MK; Lee HW; Lee WK; Park SY; Hur K
Genes (Basel); 2022 Aug; 13(8):. PubMed ID: 36011395
[TBL] [Abstract][Full Text] [Related]
17. Noncoding RNAs Serve as Diagnosis and Prognosis Biomarkers for Hepatocellular Carcinoma.
Tan C; Cao J; Chen L; Xi X; Wang S; Zhu Y; Yang L; Ma L; Wang D; Yin J; Zhang T; John Lu Z
Clin Chem; 2019 Jul; 65(7):905-915. PubMed ID: 30996051
[TBL] [Abstract][Full Text] [Related]
18. Analysis of competing endogenous RNA network identifies a poorly differentiated cancer-specific RNA signature for hepatocellular carcinoma.
Chen QF; Huang T; Si-Tu QJ; Wu P; Shen L; Li W; Huang Z
J Cell Biochem; 2020 Mar; 121(3):2303-2317. PubMed ID: 31642123
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA UPK1A-AS1 indicates poor prognosis of hepatocellular carcinoma and promotes cell proliferation through interaction with EZH2.
Zhang DY; Sun QC; Zou XJ; Song Y; Li WW; Guo ZQ; Liu SS; Liu L; Wu DH
J Exp Clin Cancer Res; 2020 Oct; 39(1):229. PubMed ID: 33121524
[TBL] [Abstract][Full Text] [Related]
20. The diagnostic and prognostic value of exosome-derived long non-coding RNAs in cancer patients: a meta-analysis.
Mu H; Zhang S; Yao Z; Liu Y; Lin K; Zhao Z; Zhu Y
Clin Exp Med; 2020 Aug; 20(3):339-348. PubMed ID: 32504320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
